XML 57 R41.htm IDEA: XBRL DOCUMENT v3.25.1
Schedule of Components of Deferred Tax Assets (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]    
Research credits $ 652,000 $ 612,000
Capitalized research and development 900,000 844,000
Stock-based compensation 1,550,000 1,631,000
Net operating loss carryforwards 9,515,000 8,601,000
Total deferred tax assets 12,617,000 11,688,000
Valuation allowance (12,617,000) (11,688,000)
Net deferred tax assets